These emerging medications , including Rybelsus, belong to a class of drugs called GLP-1 receptor agonists . Originally intended for treating type 2 diabetes , they work by assisting the body to release more insulin and limiting increased sugar levels. Additionally , their potential to promote weight loss has led to substantial attention and consid